These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3928105)

  • 21. Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect.
    Engleman EG; Benike CJ; Hoppe RT; Kaplan HS; Berberich FR
    J Clin Invest; 1980 Jul; 66(1):149-58. PubMed ID: 6447164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased sensitivity of lymphocytes from patients with Hodgkin's disease to concanavalin A-induced suppressor cells.
    Vanhaelen CP; Fisher RI
    J Immunol; 1981 Sep; 127(3):1216-20. PubMed ID: 6455471
    [No Abstract]   [Full Text] [Related]  

  • 23. Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: implications in Hodgkin's lymphoma.
    Chemnitz JM; Driesen J; Classen S; Riley JL; Debey S; Beyer M; Popov A; Zander T; Schultze JL
    Cancer Res; 2006 Jan; 66(2):1114-22. PubMed ID: 16424048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiosensitivity of Hodgkin's disease lymphocytes.
    Baral E; Blomgren H; Rotstein S
    J Clin Lab Immunol; 1981 Mar; 5(2):101-5. PubMed ID: 7218327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity.
    Passwell J; Levanon M; Davidsohn J; Ramot B
    Clin Exp Immunol; 1983 Jan; 51(1):61-8. PubMed ID: 6572580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma.
    Marshall NA; Culligan DJ; Tighe J; Johnston PW; Barker RN; Vickers MA
    Exp Hematol; 2007 Apr; 35(4):596-604. PubMed ID: 17379070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
    Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
    J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent expression of IL-7 gene transcripts in tumor cells of classical Hodgkin's disease.
    Foss HD; Hummel M; Gottstein S; Ziemann K; Falini B; Herbst H; Stein H
    Am J Pathol; 1995 Jan; 146(1):33-9. PubMed ID: 7856736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of human IL 2 production by MDP and derivatives.
    Leclerc C; Morin A; Deriaud E; Chedid L
    J Immunol; 1984 Oct; 133(4):1996-2000. PubMed ID: 6332144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to and production of interleukin 2 by peripheral blood and cerebrospinal fluid lymphocytes of patients with multiple sclerosis.
    Merrill JE; Mohlstrom C; Uittenbogaart C; Kermaniarab V; Ellison GW; Myers LW
    J Immunol; 1984 Oct; 133(4):1931-7. PubMed ID: 6088630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normal active rosette-forming-cells in untreated patients with Hodgkin's disease.
    Lang JM; Bigel P; Oberling F; Mayer S
    Biomedicine; 1977 Dec; 27(9-10):322-4. PubMed ID: 606306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
    Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
    Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease.
    Dukers DF; Jaspars LH; Vos W; Oudejans JJ; Hayes D; Cillessen S; Middeldorp JM; Meijer CJ
    J Pathol; 2000 Feb; 190(2):143-9. PubMed ID: 10657011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The patterns of IL2, IFN-gamma, IL4 and IL5 gene expression in Hodgkin's disease and reactive lymph nodes are similar.
    Serrano D; Ghiotto F; Roncella S; Airoldi I; Cutrona G; Truini M; Burgio VL; Baroni CD; Ferrarini M; Pistoia V
    Haematologica; 1997; 82(5):542-9. PubMed ID: 9407718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stage-dependent reduction in T colony formation in Hodgkin's disease. Coincidence with monocyte synthesis of prostaglandins.
    Bockman RS
    J Clin Invest; 1980 Sep; 66(3):523-31. PubMed ID: 6967491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of polyactin A on in vitro IL-2 production and responsiveness of human lymphocytes].
    Hu QL; Wang H; Wang YS; Chen RX; Shen WM
    Yao Xue Xue Bao; 1990; 25(5):326-9. PubMed ID: 2284949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients.
    Gergely L; Aleksza M; Váróczy L; Ponyi A; Sipka S; Illés A; Szegedi G
    Eur J Haematol; 2004 May; 72(5):336-41. PubMed ID: 15059068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.